-
- Two main types: Localized and systemic
- 300,000 cases in the USScleroderma Foundation: What Is Scleroderma?
- Affects 1 per 1,000 peopleScleroderma Foundation: What Is Scleroderma?
- Commonly begins between 30 to 50 yearsScleroderma Foundation: What Is Scleroderma?
- 80% of cases are womenScleroderma Foundation: What Is Scleroderma?
- No known prevention
- Not contagious or cancerous
-
-
Scleroderma is an autoimmune disease in which the body's immune system attacks the connective tissue causeing changes in the skin, blood vessels, muscles, lungs, gastrointestinal tract, heart and joints.
-
Symptoms
Common symptoms include a numb sensation or discoloring of the fingers and other extremities from cold, swelling or stiffness of joints, sores along the joints, swollen hands or feet and digestive problems.Treatment
Treatment of scleroderma includes taking blood pressure medications and covering the hands to protect them and keep them warm. Low doses of aspirin are often administered to prevent clots. Various other medications are used to handle other symptoms.-
-
Scleroderma Discussion and Blogs
- Yahoo! Health: Support for Families
- I Have Scleroderma: By People with Scleroderma, for People with Scleroderma
- This page was created by Chantal R, a Part Time Guide in the Mahalo Greenhouse (see the original), and curated by Daryn.
- If you'd like to help us create the best spam free search results on the Internet, apply to be a Part Time Guide!</em>
-
On Twitter Powered by Twitter
-
stdy 2 eval safety & tolerability of multiple doses of medi-546 in adult ppl w/ scleroderma http://bit.ly/87tWyR
-
safety evaluation of dasatinib in ppl w/ scleroderma pulmonary fibrosis http://bit.ly/6hYJNK
-
comp of therapeutic regimens 4 scleroderma interstitial lung disease http://bit.ly/8fHBhw
-
comp of therapeutic regimens 4 scleroderma interstitial lung disease http://bit.ly/7Dh7Lq
-
stdy 2 eval safety & tolerability of multiple doses of medi-546 in adult ppl w/ scleroderma http://bit.ly/4JgsOT
view more tweets...
-
About this page
-
Page Views0
This page currently has no vertical manager.
